Wall Street analysts expect that K2M Group Holdings Inc (NASDAQ:KTWO) will announce ($0.22) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for K2M Group’s earnings, with the highest EPS estimate coming in at ($0.19) and the lowest estimate coming in at ($0.24). K2M Group posted earnings of ($0.26) per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 15.4%. The firm is scheduled to report its next quarterly earnings report on Tuesday, May 1st.
According to Zacks, analysts expect that K2M Group will report full-year earnings of ($0.73) per share for the current financial year, with EPS estimates ranging from ($0.75) to ($0.70). For the next fiscal year, analysts expect that the company will post earnings of ($0.50) per share, with EPS estimates ranging from ($0.57) to ($0.43). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover K2M Group.
K2M Group (NASDAQ:KTWO) last announced its quarterly earnings results on Wednesday, February 28th. The medical device company reported ($0.20) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.19) by ($0.01). K2M Group had a negative net margin of 14.40% and a negative return on equity of 14.85%. The company had revenue of $67.80 million during the quarter, compared to analyst estimates of $67.36 million. During the same quarter last year, the company posted ($0.30) EPS. The firm’s quarterly revenue was up 9.7% on a year-over-year basis.
A number of analysts have issued reports on KTWO shares. BidaskClub raised shares of K2M Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th. Needham & Company LLC downgraded shares of K2M Group from a “strong-buy” rating to a “buy” rating and cut their price objective for the company from $26.00 to $20.00 in a report on Friday, December 8th. Barclays reissued a “buy” rating and issued a $25.00 price objective on shares of K2M Group in a report on Tuesday, January 9th. Oppenheimer set a $24.00 price objective on shares of K2M Group and gave the company a “buy” rating in a report on Thursday, March 1st. Finally, Zacks Investment Research raised shares of K2M Group from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company. K2M Group currently has a consensus rating of “Buy” and a consensus target price of $24.50.
Several institutional investors have recently modified their holdings of KTWO. Cubist Systematic Strategies LLC lifted its holdings in shares of K2M Group by 7,765.0% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 4,719 shares of the medical device company’s stock worth $100,000 after acquiring an additional 4,659 shares during the period. Teacher Retirement System of Texas bought a new stake in shares of K2M Group during the 4th quarter worth approximately $213,000. Trexquant Investment LP bought a new stake in shares of K2M Group during the 3rd quarter worth approximately $223,000. Quantbot Technologies LP lifted its holdings in shares of K2M Group by 275.9% during the 3rd quarter. Quantbot Technologies LP now owns 10,593 shares of the medical device company’s stock worth $224,000 after acquiring an additional 7,775 shares during the period. Finally, Oppenheimer Asset Management Inc. bought a new stake in shares of K2M Group during the 3rd quarter worth approximately $347,000. 99.76% of the stock is owned by institutional investors.
Shares of K2M Group (KTWO) opened at $20.22 on Tuesday. The company has a quick ratio of 1.52, a current ratio of 2.84 and a debt-to-equity ratio of 0.30. The stock has a market cap of $858.65, a PE ratio of -23.24 and a beta of 1.42. K2M Group has a twelve month low of $16.44 and a twelve month high of $25.99.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of US & international copyright & trademark legislation. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/04/07/0-22-earnings-per-share-expected-for-k2m-group-holdings-inc-ktwo-this-quarter.html.
About K2M Group
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Get a free copy of the Zacks research report on K2M Group (KTWO)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.